Knee osteoarthritis (OA) is a common debilitating chronic disease. Up to one in 5 people over the age of 45 suffer from knee OA and typical symptoms include significant pain, restricted mobility and difficulty to indulge in activities of daily living. Other than knee replacement, no other reliable treatment exists to manage symptomatic knee OA. Platelet Rich Plasma (PRP) is a form of Prolotherapy and is increasingly used to manage OA patients, although the evidence is largely anecdotal. We conducted a case-control study to assess efficacy of PRP comparing it for pain relief in OA Knee. We studied two groups of 25 patients each. One group of 25 patients was given therapeutic exercises and Acetaminophen for pain relief (control group). ...
Osteoarthritis (OA) is a degenerative disease involving joint damage, an inadequate healing response...
Osteoarthritis (OA) is the most common joint disease and the prevalence of knee OA among athletes is...
Platelet-Rich Plasma (PRP) has emerged as a promising treatment of OA, particularly in large joints....
Introduction: Osteoarthritis (OA) is a chronic joint disease that usually occurs in older people and...
Knee osteoarthritis (OA) is estimated to affect more than 10% of the population, with a lifetime ris...
International audienceBackground: Evidence is growing regarding the ability of platelet-rich plasma ...
Platelet-rich plasma (PRP) is an autologous blood product with widespread use in recent years to inc...
Whether the complex and time-intensive requirements for administering PRP warrants its use for intra...
Context There is no definite treatment strategy capable of decreasing destruction of cartilage and e...
Introduction: Osteoarthritis (OA) is the most frequently presented joint disorder, and its treatment...
Osteoarthritis (OA) is a degenerative disease involving joint damage, an inadequate healing response...
Background: Knee osteoarthritis (OA) causes substantial pain, physical dysfunction and impaired qual...
Abstract Background Knee osteoarthritis (OA) causes substantial pain, physical dysfunction and impai...
Introduction Knee osteoarthritis (OA) is the most common articular disease. Different methods are us...
Osteoarthritis (OA) is a degenerative disease involving joint damage, an inadequate healing response...
Osteoarthritis (OA) is the most common joint disease and the prevalence of knee OA among athletes is...
Platelet-Rich Plasma (PRP) has emerged as a promising treatment of OA, particularly in large joints....
Introduction: Osteoarthritis (OA) is a chronic joint disease that usually occurs in older people and...
Knee osteoarthritis (OA) is estimated to affect more than 10% of the population, with a lifetime ris...
International audienceBackground: Evidence is growing regarding the ability of platelet-rich plasma ...
Platelet-rich plasma (PRP) is an autologous blood product with widespread use in recent years to inc...
Whether the complex and time-intensive requirements for administering PRP warrants its use for intra...
Context There is no definite treatment strategy capable of decreasing destruction of cartilage and e...
Introduction: Osteoarthritis (OA) is the most frequently presented joint disorder, and its treatment...
Osteoarthritis (OA) is a degenerative disease involving joint damage, an inadequate healing response...
Background: Knee osteoarthritis (OA) causes substantial pain, physical dysfunction and impaired qual...
Abstract Background Knee osteoarthritis (OA) causes substantial pain, physical dysfunction and impai...
Introduction Knee osteoarthritis (OA) is the most common articular disease. Different methods are us...
Osteoarthritis (OA) is a degenerative disease involving joint damage, an inadequate healing response...
Osteoarthritis (OA) is the most common joint disease and the prevalence of knee OA among athletes is...
Platelet-Rich Plasma (PRP) has emerged as a promising treatment of OA, particularly in large joints....